Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
genentech
4
×
ipo
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
allergan
amgen
biogen
bristol-myers squibb
cancer
celgene
clinical trials
drug prices
What
bio
roundup
biotech
drugs
pharmaceutical
aiming
alzheimer’s
ambys
appetite
august
big
black
bread
busy
butter
buyout
cancer
cash
companies
control
days
deadly
deal
debuted
decisions
devices
diabetes
diamond’s
different
diseases
drug
eli
fail
fda
formed
future
gene
giant
grabbed
hasn’t
Language
unset
Current search:
genentech
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
